Mobile Ecological Momentary Assessment for Peripheral Neuropathy

Abbott Northwestern Hospital, Minneapolis, MN
Peripheral NeuropathyMobile Ecological Momentary Assessment - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether early lower extremity CIPN symptoms can predict which cancer patients being treated with neurotoxic chemotherapy are at risk for falling.

Eligible Conditions
  • Chemotherapy-induced Peripheral Neuropathy

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Through study completion, up to 6 months

Month 6
Patient Adherence to mEMA
Patient satisfaction with mEMA

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

mEMA Arm
1 of 1

Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Mobile Ecological Momentary Assessment · No Placebo Group · N/A

mEMA Arm
Experimental Group · 1 Intervention: Mobile Ecological Momentary Assessment · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, up to 6 months

Who is running the clinical trial?

Allina Health SystemLead Sponsor
55 Previous Clinical Trials
1,174,874 Total Patients Enrolled
Laura Gilchrist, PhDPrincipal InvestigatorAllina Health
Ginger Carroll, MS, OT/LPrincipal InvestigatorAllina Health

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able to use your eyes, ears, and mouth (with or without help from devices).

Frequently Asked Questions

What is the total number of participants involved in this trial?

"Affirmative, the page shows that this medical trial is recruiting participants at present. This clinical experiment was first advertised on March 1st 2022 and has since been updated April 8th 2022. Currently, 40 patients are needed to take part in the study from one location." - Anonymous Online Contributor

Unverified Answer

Are there any available patient positions in this experiment?

"As per information located on the website, this medical trial is open for enrollment. The initial posting date was January 3rd 2022 and the most recent update was published April 8th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.